DNA Blood Test Detects Lung Cancer Mutations
Circulating tumour DNA in blood a valid option for EGFR testing in patients who do not have accessible tumour tissue, study shows
ESMO Media Releases
One in Four Advanced Lung Cancer Patients Tested for EGFR Mutations Started on First-line Treatment Before Test Results Available
Lack of test results may impact treatment effectiveness and survival, survey in Europe, Asia and US reveals
Smokers Underestimate Risks of a Few Cigarettes
Survey shows that many live in ‘denial’ of the real risks of smoking even a small number of cigarettes a day
Evidence Grows that Melanoma Drugs Benefit some Lung Cancer Patients
Many patients with BRAF-mutant cancers benefit from treatment with BRAF inhibitors, European researchers report at ELCC
First Heine H. Hansen Award goes to Pieter E. Postmus
The award will be presented at the European Lung Cancer Conference (ELCC) 2015, held 15 to 18 April in Geneva, Switzerland
Clinical Trial Design in the Era of Targeted Therapies
A course dedicated to educating the next generation of oncologists about the essentials of clinical trial design, implementation, and analysis, will be organised this week by ESMO
World Cancer Day 2015
On World Cancer Day 2015, ESMO acknowledges patient’s right to access treatment and highlights collaborative efforts towards improving access for all
ESMO Delivers on Dynamic Force Strategy to Improve Cancer Research in Europe
New website section dedicated to research funding opportunities created to promote and improve clinical cancer research in Europe
High-dose interleukin-2 effective in mRCC pre-treated with VEGF-targeted therapies
High-dose interleukin-2 can be effective in selected metastatic renal cell cancer patients pre-treated with VEGF-targeted agents, reveals research presented today at the ESMO Symposium on Immuno-Oncology in Geneva, Switzerland.
Immune Checkpoint Inhibitors May Work in Brain Cancer
New evidence that immune checkpoint inhibitors may work in glioblastoma and brain metastases was presented today by Dr Anna Sophie Berghoff at the ESMO Symposium on Immuno-Oncology 2014 in Geneva, Switzerland
Possibilities for Personalised Vaccines Revealed at ESMO Symposium
The possibilities for personalised vaccines in all types of cancer are revealed today in a lecture from Dr Harpreet Singh at the ESMO Symposium on Immuno-Oncology 2014 in Geneva, Switzerland